Feb. 21, 2025
by Roman Kasianov
News
Roche has unveiled its proprietary Sequencing by Expansion (SBX) technology, marking its return to the next-generation sequencing (NGS) space. SBX …
Feb. 21, 2025
by Roman Kasianov
News
A recent study from researchers affiliated with Insilico Medicine has identified Traf2- and Nck-interacting kinase (TNIK) inhibition as a potential …
Feb. 21, 2025
by Roman Kasianov
News
Illumina has announced a collaboration with the Broad Institute on a Spatial Flagship Project aimed at advancing spatial transcriptomics research …
Feb. 21, 2025
by Roman Kasianov
News
At St. Jude Children’s Research Hospital in Memphis, Tennessee, a novel approach to treating spinal muscular atrophy (SMA) was tested …
Feb. 21, 2025
by BiopharmaTrend
News
Variational AI has announced the completion of a $5.5 million Seed extension round to support the market expansion of its …
Feb. 20, 2025
by Roman Kasianov
News
Evo 2, the largest AI foundation model for biology to date, is now publicly available via NVIDIA BioNeMo (Arc Institute's …
Feb. 20, 2025
by Roman Kasianov
News
Spore.Bio, a Paris-based deeptech startup, has raised $23 million in a Series A funding round, led by Singular, just two …
Feb. 19, 2025
by Roman Kasianov
News
The recent turmoil surrounding federal research funding—including the NIH policy to cap indirect costs at 15%—has left many early-stage biotech …
Feb. 17, 2025
by Bea Mann, PhD
Biopharma insight
In recent years, therapeutic capabilities in oncology have grown dramatically, with a vast array of advanced treatments progressing through clinical …
Feb. 14, 2025
by Illia Petrov
News
Insilico Medicine has released benchmarks detailing the timelines and development metrics for 22 preclinical candidate (PCC) nominations achieved between 2021 …
Feb. 13, 2025
by BiopharmaTrend
News
Latent Labs, a company developing AI models for computational protein design, has raised $50 million in funding and announced its …
Feb. 10, 2025
by Roman Kasianov
News
Receptor.AI and Moexa Pharmaceuticals Limited have announced a partnership to accelerate the development of Moexa’s SMAD3 inhibitors for cancer and …